SupplierRadar

Merck Kommanditgesellschaft auf Aktien

FDA import alert and refusal historyDarmstadt, GermanyFEI 3002806906

Watch this supplier

Watch this supplier

Get an email when FDA publishes anything new on Merck Kommanditgesellschaft auf Aktien.

Enter your work email and confirm with the link we send. Your first supplier is free, with no password and no card.

Example subjectMerck Kommanditgesellschaft auf Aktie added to Import Alert 16-129 (red list)

Free for one supplier. No password, no card.

As of October 26, 2026, Merck Kommanditgesellschaft auf Aktien is not on any FDA import alert in SupplierRadar's records; FDA refused 2 of its shipment lines on July 17, 2026, most often for unapproved new drug (UNAPPROVED).

Data from FDA public records, last checked . Request a correction

Current status

Import alerts
Not listed
Last import refusal
Vitamin b1 (thiamine) · UNAPPROVED
Last warning letter
None found
Last inspection
None on record

Every FDA record for Merck Kommanditgesellschaft auf Aktien

2 records, newest first. Each line links to the FDA page it came from.

2026

  1. Import refusal
    Refused, 2 lines in one entry: Vitamin b1 (thiamine)UNAPPROVEDEntry AEK-0791122-4Show 2 lines
    Source

Refusal charges, in plain English

  • UNAPPROVED2 refused lines

    Unapproved new drug

    The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

Questions about Merck Kommanditgesellschaft auf Aktien

Is Merck Kommanditgesellschaft auf Aktien on an FDA import alert?
No listing for Merck Kommanditgesellschaft auf Aktien appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the Germany page.
Has FDA refused shipments from Merck Kommanditgesellschaft auf Aktien?
Yes. FDA refused 2 shipment lines from Merck Kommanditgesellschaft auf Aktien on July 17, 2026. The most recent, on July 17, 2026, was vitamin b1 (thiamine), charged as UNAPPROVED (unapproved new drug).
Why did FDA refuse Merck Kommanditgesellschaft auf Aktien's shipments?
The most frequent charge is UNAPPROVED (unapproved new drug, 2 lines).
What is Merck Kommanditgesellschaft auf Aktien's FEI number?
Merck Kommanditgesellschaft auf Aktien's FDA Establishment Identifier (FEI) is 3002806906.

Buying from Merck Kommanditgesellschaft auf Aktien?

Watch it and get the FDA record the day it changes. Free for one supplier.

Watch this supplier

Watch this supplier

Get an email when FDA publishes anything new on Merck Kommanditgesellschaft auf Aktien.

Enter your work email and confirm with the link we send. Your first supplier is free, with no password and no card.

Example subjectMerck Kommanditgesellschaft auf Aktie added to Import Alert 16-129 (red list)

Free for one supplier. No password, no card.

SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.